Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2006, p. 3897-3900, Vol. 50, No. 11
0066-4804/06/$08.00+0 doi:10.1128/AAC.00057-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Peter C. Appelbaum,2
Mark van der Linden,1 and
Ralf René Reinert1*
Institute of Medical Microbiology, National Reference Center for Streptococci, University Hospital, Aachen, Germany,1 Hershey Medical Center, Hershey, Pennsylvania2
Received 13 January 2006/ Returned for modification 13 March 2006/ Accepted 30 July 2006
Telithromycin-nonsusceptible pneumococcal clinical isolates (n = 17) were analyzed for their antimicrobial susceptibility, macrolide resistance mechanisms, and genetic relatedness. All strains showed the erm(B) genotype and showed a wide range of combinations of macrolide resistance mechanisms. The predominant clone (n = 7) was serotype 14, sequence type 143.
Present address: German Jordanian University, School of Applied Medical Sciences, Amman, Jordan.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»